# CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

> **NCT05609916** · NA · RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Cognitive Behavioral Therapy
- Obsessive-Compulsive Disorder
- Obsessive-Compulsive Disorder in Children
- Obsessive-Compulsive Disorder in Adolescence

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy

## Key facts

- **NCT ID:** NCT05609916
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05609916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05609916, "CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05609916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*